Author:
Wang Shaoyu,Zheng Qiaomei,Wang Jinhua,Chen Shaozhan,Chen Lihong
Abstract
Background: Long non-coding RNAs (lncRNAs) have been confirmed to play vital roles in tumorigenesis. LncRNA MYU has recently been reported as an oncogene in several kinds of tumors. However, MYU’s expression status and potential involvement in ovarian cancer (OC) remain unclear. In this study, we explored the underlying role of MYU in OC.Methods and results: The expression of MYU was upregulated in OC tissues, and MYU’s overexpression was significantly correlated with the FIGO stage and lymphatic metastasis. Knockdown of MYU inhibited cell proliferation in SKOV3 and A2780 cells. Mechanistically, MYU directly interacted with miR-6827-5p in OC cells; HMGA1 is a downstream target gene of miR-6827-5p. Furthermore, MYU knockdown increased the expression of miR-6827-5p and decreased the expression of HMGA1. Restoration of HMGA1 expression reversed the influence on cell proliferation caused by MYU knockdown.Conclusion: MYU functions as a ceRNA that positively regulates HMGA1 expression by sponging miR-6827-5p in OC cells, which may provide a potential target and biomarker for the diagnosis or prognosis of OC.
Subject
Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine
Reference28 articles.
1. Cancer statistics in China and United States, 2022: Profiles, trends, and determinants;Xia;Chin Med J,2022
2. Epigenetic therapy for ovarian cancer: Promise and progress;Moufarrij;Clin epigenetics,2019
3. Ovarian cancer statistics;Torre;CA Cancer J Clin,2018
4. Non-coding RNAs in development and disease: Background, mechanisms, and therapeutic approaches;Beermann;Physiol Rev,2016
5. Emerging epigenetic mechanisms of long non-coding RNAs;Schaukowitch;Neuroscience,2014
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献